Insider Transactions in Q1 2022 at Nurix Therapeutics, Inc. (NRIX)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 10
2022
|
Christine Ring Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,200
-48.27%
|
$32,400
$27.14 P/Share
|
|
Jan 10
2022
|
Christine Ring Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,200
+32.56%
|
$1,200
$1.86 P/Share
|
|
Jan 03
2022
|
Gwenn Hansen Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,828
-11.41%
|
$51,184
$28.96 P/Share
|
|
Jan 03
2022
|
Gwenn Hansen Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,828
+5.42%
|
$14,624
$8.42 P/Share
|